Rating History for MBX Biosciences Inc (MBX) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
66.00 (N/A) |
36.60 (30.55) |
-16.53% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/28/2026 | Eliana Merle | New Coverage | Overweight (N/A) |
66.00 (N/A) |
36.60 (30.55) |
-16.53% | Details |